As pharmaceutical companies expand into new markets in Asia and Latin America, supply chain security teams often find themselves struggling to address risk in their rapidly-multiplying trade lanes. Meanwhile, the threat of pharmaceutical theft and tampering continues to exist in established markets such as the United States and Italy. Trade lane risk assessments can help supply chain security teams at rapidly-growing pharmaceutical companies understand where their greatest risks lie and help justify appropriate mitigation measures. BSI's webinar on trade lane risk assessments will discuss the different types of risk assessments pharmaceutical companies can use, the basics of conducting trade lane risk assessments, and the benefits of performing these assessments in both new and established pharmaceutical markets.